IJID Regions is a pioneering open access journal published by Elsevier, focusing on the critical fields of epidemiology, infectious diseases, and public health. Established in 2021, the journal aims to provide a platform for disseminating high-quality, innovative research that addresses pressing health issues and informs evidence-based practices in communities around the globe. With its impact factors reflecting a Tier Q2 and Q3 ranking in various medical subcategories on the Scopus platform, IJID Regions is positioned as a valuable resource for researchers, health professionals, and policy-makers striving to enhance public health outcomes. This journal not only champions open access since its inception, promoting the free flow of information, but also welcomes contributions that shed light on contemporary challenges in environmental and occupational health. Its commitment to fostering dialogue and collaboration in the health sciences is paramount, making it an essential read for those engaged in advancing public health knowledge and initiatives.

ACTA TROPICA is a prestigious academic journal published by Elsevier, dedicated to advancing knowledge in the fields of Infectious Diseases, Insect Science, Parasitology, and Veterinary sciences. With an ISSN of 0001-706X and an E-ISSN of 1873-6254, it has established itself as a vital resource since its inception in 1945. The journal is recognized for its significant impact within the scientific community, boasting a Q2 ranking in Infectious Diseases and Parasitology, and a Q1 ranking in both Insect Science and Veterinary (miscellaneous) categories as of 2023. Specifically, it ranks #19 in Scopus for Parasitology and #129 for Infectious Diseases, underscoring its high visibility and relevance in these vital research arenas. ACTA TROPICA is a non-open access journal, ensuring high-quality peer-reviewed content that complements ongoing research and professional practices among scientists, researchers, and students. Explore groundbreaking studies and contribute to the ongoing dialogue within your field by selecting ACTA TROPICA as your next publication destination.

Revista da Sociedade Brasileira de Medicina Tropical is a distinguished open-access journal published by the Sociedade Brasileira de Medicina Tropical, focusing on the critical fields of Infectious Diseases, Microbiology, and Parasitology. Since its inception in 1972, this journal has committed to disseminating impactful research that addresses pressing global health challenges, particularly in tropical and infectious diseases prevalent in Brazil and beyond. With a robust publication history, it has been recognized as a Q3 journal in esteemed categories, reflecting its valuable contributions to scientific literature and its ranking in various Scopus categories, including a notable position in Parasitology. Researchers, professionals, and students are encouraged to engage with its rich repository of research, which has been freely accessible since 1997, fostering a wide-reaching impact on public health strategy and scientific innovation.

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.

Journal of Tropical Medicine, published by HINDAWI LTD, is a leading open-access journal dedicated to the dissemination of high-quality research within the field of tropical medicine. With an ISSN of 1687-9686 and E-ISSN 1687-9694, this journal has been providing an essential platform for researchers since 2009, facilitating a comprehensive understanding of diseases affecting tropical regions. Based in Egypt, the journal is categorized in the Q2 quartile for Medicine (miscellaneous) and Parasitology, alongside a Q3 rank in Microbiology as of 2023, highlighting its significant impact and relevance in these critical fields. The journal has earned commendable rankings within Scopus, being positioned 136th out of 636 in General Medicine, which reflects its role in advancing tropical health research. The Journal of Tropical Medicine is committed to promoting accessibility and knowledge sharing, making it an indispensable resource for professionals, researchers, and students dedicated to eradicating diseases and improving health outcomes in tropical settings.

VIROLOGIE is a prominent international journal dedicated to advancing the field of virology and infectious diseases, published by John Libbey Eurotext Ltd. Since its inception in 1997, this journal has provided a platform for researchers and professionals to disseminate their findings on various aspects of virology, including the pathogenesis, epidemiology, and treatment of viral infections. Despite its current ranking in Q4 for both Infectious Diseases and Virology categories, the journal remains a valuable resource for emerging research and novel insights. The ISSN for the journal is 1267-8694, and it is based in France. VIROLOGIE is committed to upholding rigorous academic standards and fosters an inclusive scholarly community, making it an essential read for those pursuing knowledge and advancements in the ever-evolving landscape of virology. While the journal does not currently offer open access options, it continues to contribute significantly to the global discourse on viral research through its diverse range of published studies.

Parasite Epidemiology and Control is a premier open-access journal published by Elsevier, dedicated to advancing the understanding of parasites and their impact on public health. Since its inception in 2016, the journal has established itself as a prominent publication in the fields of epidemiology, infectious diseases, and parasitology, achieving a commendable classification of Q2 in these categories as per 2023 metrics. With its ISSN 2405-6731, the journal serves as a vital resource for researchers, practitioners, and students, offering rigorous, peer-reviewed articles that illuminate parasite-related epidemiological trends and control strategies. Based in the United Kingdom, Parasite Epidemiology and Control actively promotes open access, ensuring that crucial research findings are readily accessible to a global audience, thus enhancing collaborative efforts in tackling parasitic diseases. The journal's impact is reflected in its Scopus rankings—ranking 17th in Parasitology among 79 journals, 47th in Epidemiology among 148, and 121st in Infectious Diseases among 344—underlining its significance in the scientific community. Join us in exploring this critical field and contributing to the fight against parasitic diseases through innovative research and shared knowledge.

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

BMC Veterinary Research, published by BMC in the United Kingdom, stands as a pivotal open-access platform dedicated to advancing the field of veterinary science since its inception in 2005. With an impressive impact factor that reflects its influential presence, this journal has achieved a remarkable ranking of #17 out of 194 in the Scopus Veterinary category, placing it in the 91st percentile among its peers. The journal serves as an essential resource for researchers, professionals, and students alike, fostering the dissemination of high-quality research and innovative practices within the veterinary and broader medical communities. With its commitment to open access, BMC Veterinary Research ensures that valuable insights are accessible to all, promoting collaboration and knowledge sharing that drive the advancement of veterinary sciences. As it continues to publish significant findings until 2024, it remains a key contributor to the contemporary discourse on animal health and welfare.

Asian Pacific Journal of Tropical Medicine, published by Wolters Kluwer Medknow Publications, stands at the forefront of research in the field of tropical medicine, contributing significantly to the global understanding of health issues prevalent in the Asian Pacific region. With an ISSN of 1995-7645 and an E-ISSN of 2352-4146, this esteemed journal has been an Open Access platform since 2011, ensuring that vital research is accessible to a broad audience. The journal boasts a commendable Scopus rank of 131 out of 636 in the General Medicine category, placing it in the 79th percentile and recognizing its influential contributions to the discipline. Based in Mumbai, India, the journal spans converged years from 2010 to 2024 and is categorized in the Q3 quartile for miscellaneous medicine as of 2023. Researchers, professionals, and students can leverage this journal to stay abreast of the latest findings and developments in tropical medicine, making it an indispensable resource in their academic and professional pursuits.